• 1. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 2. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 3. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 4. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 5. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenols Methoxyphenols

Introduction to 2-Fluoro-6-hydroxy-3-methoxybenzaldehyde (CAS No. 783342-35-8)

2-Fluoro-6-hydroxy-3-methoxybenzaldehyde, identified by its Chemical Abstracts Service (CAS) number CAS No. 783342-35-8, is a fluorinated aromatic aldehyde that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound, characterized by its hydroxyl and methoxy substituents, exhibits a unique structural framework that makes it a valuable intermediate in the synthesis of various biologically active molecules.

The< strong>fluorine atom in the molecule imparts distinct electronic and steric properties, influencing its reactivity and potential applications. The presence of both< strong>hydroxyl and< strong>methoxy groups enhances its versatility, allowing for further functionalization through various chemical transformations. These features make< strong>2-Fluoro-6-hydroxy-3-methoxybenzaldehyde a promising candidate for the development of novel therapeutic agents.

In recent years, there has been a growing interest in fluorinated compounds due to their enhanced metabolic stability, improved bioavailability, and increased binding affinity to biological targets. The< strong>fluorine-containing aromatic aldehydes, such as< strong>2-Fluoro-6-hydroxy-3-methoxybenzaldehyde, have been extensively studied for their potential in drug discovery. For instance, fluorinated aldehydes have been shown to exhibit inhibitory effects on various enzymes and receptors, making them attractive scaffolds for the development of small-molecule drugs.

One of the most compelling aspects of< strong>2-Fluoro-6-hydroxy-3-methoxybenzaldehyde is its role as a key intermediate in the synthesis of pharmacologically active compounds. Researchers have leveraged its structural features to develop molecules with therapeutic potential in areas such as oncology, inflammation, and neurodegenerative diseases. The< strong>hydroxyl and< strong>methoxy groups provide handles for further chemical modifications, enabling the creation of diverse analogues with tailored biological activities.

A notable application of< strong>2-Fluoro-6-hydroxy-3-methoxybenzaldehyde is in the synthesis of kinase inhibitors. Kinases are enzymes that play crucial roles in cell signaling pathways, and their dysregulation is often associated with various diseases, including cancer. By incorporating the< strong>fluorine-containing aromatic aldehyde into kinase inhibitors, researchers have been able to enhance their potency and selectivity. For example, studies have demonstrated that derivatives of< strong>2-Fluoro-6-hydroxy-3-methoxybenzaldehyde can effectively inhibit specific kinases while minimizing off-target effects.

The< strong>methoxy group in< strong>2-Fluoro-6-hydroxy-3-methoxybenzaldehyde also contributes to its pharmacological profile by influencing solubility and metabolic stability. This makes it an ideal candidate for further derivatization to produce compounds with improved pharmacokinetic properties. Additionally, the< strong>hydroxyl group can be utilized for hydrogen bonding interactions with biological targets, enhancing binding affinity and efficacy.

In academic research,< strong>2-Fluoro-6-hydroxy-3-methoxybenzaldehyde has been employed in various synthetic strategies to develop novel heterocyclic compounds. Heterocycles are essential components of many drugs due to their ability to mimic natural biomolecules and interact with biological targets. The incorporation of fluorine into heterocyclic frameworks has been shown to improve drug-like properties, making these compounds more suitable for therapeutic applications.

The versatility of< strong>2-Fluoro-6-hydroxy-3-methoxybenzaldehyde extends beyond its use as an intermediate in drug synthesis. It has also been explored as a building block for materials science applications. For instance, fluorinated aromatic aldehydes can be used to create functional polymers with unique properties such as enhanced thermal stability and chemical resistance. These materials find applications in industries ranging from electronics to coatings.

The synthesis of< strong>2-Fluoro-6-hydroxy-3-methoxybenzaldehyde involves multi-step organic reactions that highlight its synthetic utility. Common synthetic routes include fluorination reactions followed by selective hydroxymethylation and methylation steps. These processes showcase the compound's potential as a versatile intermediate in complex synthetic transformations.

The growing body of research on< strong>CAS No. 783342-35-8, or more accurately referred to asCAS No., underscores its importance in modern chemistry and biology.

• 887267-04-1(3,6-Difluoro-2-methoxybenzaldehyde)
• 783342-33-6(2-Fluoro-3,6-dimethoxybenzaldehyde)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)